首页> 外文期刊>Advanced Powder Technology: The internation Journal of the Society of Powder Technology, Japan >Fast release of liquid antisolvent precipitated fenofibrate at high drug loading from biocompatible thin films
【24h】

Fast release of liquid antisolvent precipitated fenofibrate at high drug loading from biocompatible thin films

机译:从生物相容性薄膜的高药物载荷下,液体抗溶剂的快速释放沉淀过芬纤维

获取原文
获取原文并翻译 | 示例
           

摘要

Motivated by recent papers on nano and micro-particle slurry casting of poorly water-soluble drugs forming biocompatible films with enhanced properties, this work explores incorporation of liquid antisolvent (LAS) precipitated suspensions of fenofibrate, a model poorly soluble drug using both semi-synthetic (HPMC E15 LV) and natural (sodium alginate, SA) polymer as film formers. Centrifugation and subsequent resuspension were employed to minimize residual solvent and increase drug loading (~20%) in the LAS suspensions and in the film. Film’s critical quality attributes (CQAs), including drug distribution and uniformity, mechanical properties, and dissolution were assessed. Crystalline nature of FNB was largely preserved in the film without any polymorphic changes confirmed by XRD, DSC, and Raman. The NIR chemical imaging, corroborated by SEM imaging and drug content relative standard deviation (RSD) indicates that the drug is uniformly distributed without any observable large agglomerates. The films with SA showed lower mechanical strength as compared to HPMC due to SA’s low molecular weight. All films exhibited immediate drug release as has been the case using FNB nano particles in previous papers. Interestingly, although addition of plasticizer improved film dissolution, HPMC-based films had a faster dissolution compared to SA-based films in spite of higher mechanical strength of the former.
机译:最近的纳米和微颗粒浆料铸造的临床和微颗粒浆料铸造的较差的水溶性药物,具有增强性能的生物相容性薄膜,这项工作探讨了液体抗溶剂(LAS)沉淀的芬太基沉淀的悬浮液,使用半合成的模型可溶于药物较差的药物(HPMC E15 LV)和天然(藻酸钠,SA)聚合物作为薄膜成型器。使用离心和随后的重悬浮,以最小化残留溶剂,并在LAS悬浮液和薄膜中增加药物负载(〜20%)。薄膜的关键质量属性(CQAS),包括药物分布和均匀性,机械性能和溶解。 FNB的结晶性质在薄膜中大部分保存,没有XRD,DSC和拉曼证实的任何多态性变化。通过SEM成像和药物含量相对标准偏差(RSD)证实的NIR化学成像表明该药在没有任何可观察到的大聚体的情况下均匀分布。与SA的低分子量相比,具有SA的薄膜显示出较低的机械强度。所有薄膜都表现出直接的药物释放,如先前纸张中使用FNB纳米颗粒的情况。有趣的是,尽管添加增塑剂改善的薄膜溶解,但由于前者的机械强度更高,基于HPMC的薄膜与基于SA的薄膜相比具有更快的溶解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号